Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income…
  • SaveTheTuaHawk@lemmy.caEnglish
    3·
    10 hours ago

    Pharmaceutical companies used to do basic research until the 90s. At this point, they are just banks who buy biotechs spun out from NIH research.

    Now that NIH is gone, the industry will atrophy within a decade. There will be no new drugs.